Inventor · disambiguated record
Weiming Xu
Also filed as: XU WEIMING
19 granted patents·4 pending applications·176 citations·filing 1997–2024
93Inventor score
Files withUNIV HANGZHOU NORMAL8SIGNAL PHARM LLC5PERRIN-NINKOVIC SOPHIE3HANGZHOU TRANSFAR FINE CHEMICAL CO LTD2CHOPRA RAJESH1
Top patents by PatentIndex Score
23 records- 0196US8492381B2Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathwayPERRIN-NINKOVIC SOPHIE·Filed 2011·Granted Jul 23, 2013·44 cites·21 claims
- 0296US8110578B2Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathwayPERRIN-NINKOVIC SOPHIE·Filed 2009·Granted Feb 7, 2012·67 cites·28 claims
- 0393US8507492B2Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathwayPERRIN-NINKOVIC SOPHIE·Filed 2011·Granted Aug 13, 2013·22 cites·20 claims
- 0490US10004735B2Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazinesSIGNAL PHARM LLC·Filed 2017·Granted Jun 26, 2018·4 cites·16 claims
- 0590US9737535B2Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazinesSIGNAL PHARM LLC·Filed 2015·Granted Aug 22, 2017·5 cites·16 claims
- 0690US9155736B2Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for TOR kinase inhibitory activitySIGNAL PHARM LLC·Filed 2013·Granted Oct 13, 2015·16 cites·6 claims
- 0785US9555033B2Identification of LKB1 mutation as a predictive biomarker for sensitivity to TOR kinase inhibitorsCHOPRA RAJESH·Filed 2011·Granted Jan 31, 2017·6 cites·14 claims
- 0883US10604466B1Method for preparing resveratrol compoundUNIV HANGZHOU NORMAL·Filed 2019·Granted Mar 31, 2020·2 cites·13 claims
- 0983US8394832B2Methods and compositions using immunomodulatory compounds for the treatment of immunodeficiency disordersXU WEIMING·Filed 2005·Granted Mar 12, 2013·8 cites·10 claims
- 1080US2023119470A1PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAYSIGNAL PHARM LLC·Filed 2022·Application pending·0 cites
- 1170US9557338B2Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for tor kinase inhibitory activitySIGNAL PHARM LLC·Filed 2015·Granted Jan 31, 2017·1 cites·4 claims
- 1266US2025041851A1Fluid-mechanical blood coagulation testingTEXAS A & M UNIV SYS·Filed 2024·Application pending·0 cites
- 1360US2025214950A1Method for preparing fluralanerUNIV HANGZHOU NORMAL·Filed 2024·Application pending·0 cites
- 1459US11414415B26H-imidazo[4,5,1-ij]quinolone, synthesis method and use thereofUNIV HANGZHOU NORMAL·Filed 2020·Granted Aug 16, 2022·0 cites·13 claims
- 1555US11577228B2Porous layered transition metal dichalcogenide and preparation method and use thereofUNIV HANGZHOU NORMAL·Filed 2020·Granted Feb 14, 2023·0 cites·14 claims
- 1652US11161818B2Quinolone derivatives, preparation methods and application thereofUNIV HANGZHOU NORMAL·Filed 2020·Granted Nov 2, 2021·0 cites·12 claims
- 1751US11161809B2Processes for preparing 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indanacetonitrile and for preparing sulindacUNIV HANGZHOU NORMAL·Filed 2020·Granted Nov 2, 2021·0 cites·20 claims
- 1849US12240938B22,2-dimethyl-1,3-dioxolan-4-yl-methyl 2-bromo-2,2-difluoroacetate, waterborne polyurethane, and preparation methods thereofHANGZHOU TRANSFAR FINE CHEMICAL CO LTD·Filed 2021·Granted Mar 4, 2025·0 cites·2 claims
- 1949US11242307B1Method for preparing alkynyl 2-halo-2,2-difluoroacetateHANGZHOU TRANSFAR FINE CHEMICAL CO LTD·Filed 2020·Granted Feb 8, 2022·0 cites·5 claims
- 2047US10611721B2Method for preparing levobunolol hydrochlorideUNIV HANGZHOU NORMAL·Filed 2018·Granted Apr 7, 2020·0 cites·13 claims
- 2146US10125119B2Series of resveratrol-derivative fluorescently labeled molecules and synthesis method thereofUNIV HANGZHOU NORMAL·Filed 2018·Granted Nov 13, 2018·0 cites·10 claims
- 2246US2013158023A1Identification of gene expression as a predictive biomarker for lkb1 statusNING YUHONG L·Filed 2012·Application pending·0 cites
- 2331US6197509B1Method of analyzing DNA using contiguous repeatsMEDICAL RES COUNCIL·Filed 1997·Granted Mar 6, 2001·1 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Weiming Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →